Heather Berger, Ph.D.

Heather Berger, Ph.D.

DirectoratDesign Therapeutics· In proxies 2023–2025

Heather Berger, Ph.D. sits on 3 public boards.

Boards1

  • Design TherapeuticsDirector · 3 yr on the boardIndependentAudit, Research and Development—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Design TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +21%
  2. Second GenomePublic company · 2 yr
    • Director2020 – 2022 · 2 yrNo stock prices for these years
  3. Entasis Therapeutics Holdings Inc.Public company · 5 yr
    • Director2017 – 2022 · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?